Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tyche IndustriesBOM:532384 +2.74%72 Days Payable is 52.93 as of Jun. 2026, which is 22% below its 10-year median of 67.92. GuruFocus rates BOM:532384 with a GF Score™ of 72/100 and a GF Value™ of ₹108.23 (Fairly Valued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Tyche Industries ranks worse than 53.95% on this metric.
The historical rank and industry rank for Tyche Industries's Days Payable or its related term are showing as below:
BOM:532384'
s Days Payable Range Over the Past 10 Years
Min: 62.73 Med: 67.92 Max: 100.09
Current: 82.31
During the past 13 years, Tyche Industries's highest Days Payable was 100.09. The lowest was 62.73. And the median was 67.92.
BOM:532384's Days Payable is ranked worse than 53.95% of 923
companies
in the Drug Manufacturers industry
Industry Median: 88.75
vs BOM:532384: 82.31
Tyche Industries's Days Payable
declined
from Jun. 2025 (133.82) to Jun. 2026 (52.93).
It may suggest that Tyche Industriesaccelerated paying its suppliers.
The historical data trend for Tyche Industries's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tyche Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tyche Industries Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tyche Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Tyche Industries's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Tyche Industries's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tyche Industries (BOM:532384) has a Days Payable of 52.93 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tyche Industries and its competitors. This is 22% below median its historical median of 67.92. Over the past decade, Tyche Industries' Days Payable has ranged from 62.73 to 100.09. According to the industry distribution chart, Tyche Industries ranks #498 out of 923 companies in the Drug Manufacturers industry, placing it in the top 54%.
Is Tyche Industries' Days Payable too high?
Tyche Industries' current Days Payable of 52.93 is 22% below median its 10-year median of 67.92. Over the past 10 years, this metric has ranged from a low of 62.73 to a high of 100.09. The Drug Manufacturers industry median Days Payable is 88.75. Tyche Industries' value of 52.93 is 40.4% below this industry median. Based on the distribution chart, Tyche Industries ranks #498 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tyche Industries has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tyche Industries' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Tyche Industries ranks #498 out of 923 companies for Days Payable. This places Tyche Industries in the lower half of its industry. The industry median Days Payable is 88.75. Tyche Industries' value of 52.93 is 40.4% below this benchmark. Historically, Tyche Industries' own Days Payable has ranged from 62.73 to 100.09 over the past decade. While the company's 10-year median is 67.92 vs. the industry median of 88.75, Tyche Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.75, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tyche Industries's current Days Payable of 52.93 is 40.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tyche Industries and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tyche Industries's current Days Payable is 52.93, which is 22% below median its own 10-year median of 67.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tyche Industries stock overvalued right now?
Based on GuruFocus' analysis, Tyche Industries (BOM:532384) is currently considered Fairly Valued. The stock's GF Value™ is ₹108.23, compared to a current price of ₹106.85 — trading 1.3% below its estimated fair value. The current Days Payable is 52.93, which is 22% below median its 10-year median of 67.92 and 40.4% below the Drug Manufacturers industry median of 88.75. Tyche Industries' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tyche Industries (BOM:532384), the current Days Payable is 52.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tyche Industries (BOM:532384) Overvalued in 2026?
Based on GuruFocus' analysis, Tyche Industries stock appears to be undervalued.
The current stock price of ₹106.85 is trading 1.3% below its estimated GF Value™ of ₹108.23.
GuruFocus considers Tyche Industries to be Fairly Valued.
Key valuation signals for BOM:532384:
Days Payable: 52.93 (22% below median its 10-year median of 67.92)
GF Value™: ₹108.23 vs. price of ₹106.85 (1.3% below fair value)
Industry Position: 40.4% below the Drug Manufacturers median (#498 of 923)
No single metric tells the full story. See the BOM:532384 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tyche Industries Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing of bulk drug intermediates. Geographically, it derives a majority of its revenue from the Export business. The company is a manufacturer in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to the USA and Europe. Its business areas include API, Intermediates, Chiral Intermediates, Nutraceuticals, and CDMO. It operates in a single segment namely the manufacture of bulk drugs intermediates.
72GF Score
Get the complete analysis for BOM:532384
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532384 has been successfully added to your 
